Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Insider Selling: BKV (NYSE:BKV) SVP Sells $103,546.32 in Stock

BKV logo with Energy background
Image from MarketBeat Media, LLC.

Key Points

  • BKV SVP Javier Hinojosa sold 4,952 shares at an average price of $20.91, generating $103,546.32. The transaction was conducted under a pre-arranged Rule 10b5-1 plan, leaving him with 71,896 shares.
  • BKV shares recently traded at $20.83, near the company’s 52-week low of $20.03 and below its 50-day and 200-day moving averages. The company has a $2.28 billion market capitalization and a price-to-earnings ratio of 7.60.
  • Analyst sentiment remains broadly positive, with an average “Buy” rating and a consensus price target of $33.67, despite one recent “Strong Sell” downgrade.
  • Want to know the moment analysts change their view on BKV? Get MarketBeat All Access for $149 a year and keep that rate for life.

BKV Corporation (NYSE:BKV - Get Free Report) SVP Javier Hinojosa sold 4,952 shares of the stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $20.91, for a total transaction of $103,546.32. Following the completion of the transaction, the senior vice president owned 71,896 shares in the company, valued at $1,503,345.36. The trade was a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Javier Hinojosa also recently made the following trade(s):

  • On Friday, September 25th, Javier Hinojosa sold 7,428 shares of BKV stock. The shares were sold at an average price of $22.66, for a total transaction of $168,318.48.
  • On Friday, August 21st, Javier Hinojosa sold 12,377 shares of BKV stock. The stock was sold at an average price of $25.73, for a total value of $318,460.21.

BKV Stock Performance

NYSE BKV traded up $0.47 on Monday, hitting $20.83. 1,759,890 shares of the company traded hands, compared to its average volume of 1,996,401. The company has a market capitalization of $2.28 billion, a price-to-earnings ratio of 7.60 and a beta of 1.13. The company has a current ratio of 1.15, a quick ratio of 1.10 and a debt-to-equity ratio of 0.45. The business's 50 day moving average price is $23.56 and its 200-day moving average price is $26.62. BKV Corporation has a 52-week low of $20.03 and a 52-week high of $32.81.

BKV (NYSE:BKV - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.46 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.21. BKV had a net margin of 17.73% and a return on equity of 6.67%. The company had revenue of $465.54 million for the quarter, compared to analysts' expectations of $355.25 million. Equities analysts expect that BKV Corporation will post 1.49 earnings per share for the current year.

Institutional Trading of BKV

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. State of Alaska Department of Revenue lifted its holdings in shares of BKV by 23.1% in the 3rd quarter. State of Alaska Department of Revenue now owns 4,160 shares of the company's stock valued at $88,000 after purchasing an additional 782 shares during the last quarter. PEAK6 LLC acquired a new position in BKV during the second quarter worth about $270,000. Arizona State Retirement System acquired a new stake in shares of BKV in the 2nd quarter worth approximately $289,000. Jupiter Topco LLC acquired a new stake in BKV in the 2nd quarter valued at about $446,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in shares of BKV during the second quarter worth about $479,000.

Wall Street Analyst Weigh In

BKV has been the subject of a number of research analyst reports. Zacks Research upgraded shares of BKV from a "hold" rating to a "strong-buy" rating in a report on Tuesday, October 6th. Truist Financial upped their target price on BKV from $33.00 to $34.00 and gave the stock a "buy" rating in a report on Wednesday, October 14th. Barclays cut their price target on BKV from $36.00 to $35.00 and set an "overweight" rating on the stock in a research note on Tuesday, September 15th. Jefferies Financial Group restated a "buy" rating and issued a $34.00 price objective on shares of BKV in a report on Friday, July 10th. Finally, Wall Street Zen lowered shares of BKV from a "sell" rating to a "strong sell" rating in a research note on Saturday, October 17th. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $33.67.

View Our Latest Stock Analysis on BKV

About BKV

(Get Free Report)

BKV Corporation is an independent energy company focused on the exploration, development and production of natural gas in the United States. The company's operations are centered on unconventional shale resources, with activities that include drilling, well completion, production and management of natural gas assets.

In addition to its upstream operations, BKV is developing complementary energy businesses, including natural gas power generation and carbon capture, utilization and storage.

Recommended Stories

Insider Buying and Selling by Quarter for BKV (NYSE:BKV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BKV Right Now?

Before you consider BKV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.

While BKV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines